Study patients were pathologically or cytologically confirmed as local advanced, or metastatic nonsquamous NSCLC without acquired EGFR T790M mutation or ALK, ROS‐1 rearrangement. This evidence concerns the gene EGFR and non-small cell lung carcinoma.